Heska

Heska FCF Yield

Delisted

The Free Cash Flow Yield of Heska (HSKA) as of Nov 1, 2026 is -1.83 %. In the previous year, Free Cash Flow Yield was 0.34 % — a change of -634.20% (lower).

FCF Yield

-1.83 %

YoY

-634.20%

Last updated:

Free Cash Flow Yield of Heska is 2022 -1.83 % . Free Cash Flow Yield of Heska was 2021 0.34 % . It decreases by -634.20% lower compared to the previous year.

The Heska FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2015
-0.13 USD
Jan 1, 2016
0.19 USD
Jan 1, 2017
0.53 USD
Jan 1, 2018
0.70 USD
Jan 1, 2019
0.17 USD
Jan 1, 2020
-0.10 USD
Jan 1, 2021
0.34 USD
Jan 1, 2022
-1.83 USD
The Heska FCF Yield history
YEARFCF YieldYoY
-1.83 %-634.20%
0.34 %-433.76%
-0.10 %-159.59%
0.17 %-75.47%
0.70 %+32.26%
0.53 %+184.66%
0.19 %-247.94%
-0.13 %-147.84%
0.26 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Heska Stock analysis

What does Heska do? Heska Corp was founded in 2001 and has since become a leading company in the field of animal health. The company is headquartered in Loveland, Colorado and has locations in the USA, Europe, and Asia. Heska's business model is based on the development, manufacturing, and marketing of innovative diagnostic and therapeutic products for animals. The company aims to provide veterinarians and pet owners with a comprehensive range of solutions to support the health and well-being of animals. Heska has divided itself into three main divisions in order to cover the entire spectrum of animal health: diagnosis, therapy, and traceability. In the "diagnosis" division, Heska offers a wide range of diagnostic test kits for various animals, including dogs, cats, horses, cattle, and pigs. The tests include blood tests, urine tests, imaging tests, and molecular diagnostics. Heska's therapy division includes products for the treatment of animals, including medications, vaccines, and pet conditioners. The company also develops innovative therapy approaches to combat diseases in animals, including oncology. Another important aspect of Heska's business model is offering targeted solutions for seamless traceability of animals for agricultural and veterinary purposes. The company offers a wide selection of animal identification products that are known for their reliability and safety. Heska is committed to continuously improving and innovating its products to help animals and pet owners worldwide. The company aims to achieve better access to healthcare for animals through its research and development in the field of animal health, thus improving the lives of all animals. In summary, Heska Corp is a significant company in the field of animal health that specializes in the development and marketing of diagnostic and therapeutic products for animals. The company's products are valued by veterinarians and pet owners worldwide and contribute to improving the health and well-being of animals. Heska is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Heska stock

Free Cash Flow Yield of Heska is -1.83 % in 2022.

Free Cash Flow Yield of Heska changed from 0.34 % to -1.83 %, representing a -634.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Heska since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Heska with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Heska

All Key Metrics — Heska